KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Current Taxes: 2016-2024

Historic Current Taxes for BeOne Medicines (ONC) over the last 9 years, with Dec 2024 value amounting to $25.9 million.

  • BeOne Medicines' Current Taxes fell 24.60% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 24.60%. This contributed to the annual value of $25.9 million for FY2024, which is 12.98% up from last year.
  • According to the latest figures from FY2024, BeOne Medicines' Current Taxes is $25.9 million, which was up 12.98% from $23.0 million recorded in FY2023.
  • BeOne Medicines' 5-year Current Taxes high stood at $25.9 million for FY2024, and its period low was $20.4 million during FY2020.
  • Moreover, its 3-year median value for Current Taxes was $25.2 million (2022), whereas its average is $24.7 million.
  • As far as peak fluctuations go, BeOne Medicines' Current Taxes spiked by 51.48% in 2020, and later declined by 8.88% in 2023.
  • BeOne Medicines' Current Taxes (Yearly) stood at $20.4 million in 2020, then grew by 4.98% to $21.4 million in 2021, then rose by 17.73% to $25.2 million in 2022, then decreased by 8.88% to $23.0 million in 2023, then climbed by 12.98% to $25.9 million in 2024.